The Asia Pacific lithotripsy market was valued at US$ 235.12 million in 2023 and is expected to reach US$ 419.89 million by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031.
By product type, the Asia Pacific lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
In term of application, the Asia Pacific lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on end user, the Asia Pacific lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on country, the Asia Pacific lithotripsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific lithotripsy market in 2023.
Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the Asia Pacific lithotripsy market.
Reasons to Buy
Rise in Mobile Lithotripsy Services Fuels Asia Pacific Lithotripsy Market
Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients' experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries in the future if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the market in the coming years.Asia Pacific Lithotripsy Market Overview
According to the AME Publishing Company report, urolithiasis is one of the most prevalent diseases in China, with patients suffering from upper urinary stones. With high prevalence and recurrence rates, urolithiasis represents a major burden on the healthcare system in the country. Therefore, with the rising prevalence of urolithiasis, there is a high demand for extracorporeal shockwave lithotripsy (ESWL). ESWL is an advanced treatment device that has been widely adopted by doctors and patients in hospitals. Additionally, there are many hospitals in China where more than 5,000 cases annually have been treated with urolithiasis, as per the Chinese Medical Association Publishing House report. Furthermore, in a few hospitals, over 10 cases were treated in one day, and ~3,000 cases every year. Therefore, the rising prevalence of urolithiasis and the high adoption of lithotripsy in hospitals are a few factors responsible for the market growth in China.Asia Pacific Lithotripsy Market Segmentation
The Asia Pacific lithotripsy market is categorized into product type, application, end user, and country.By product type, the Asia Pacific lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
In term of application, the Asia Pacific lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on end user, the Asia Pacific lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the Asia Pacific lithotripsy market share in 2023.
Based on country, the Asia Pacific lithotripsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific lithotripsy market in 2023.
Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the Asia Pacific lithotripsy market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific lithotripsy market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific lithotripsy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific lithotripsy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Lithotripsy Market - Key Market Dynamics
5. Lithotripsy Market -Asia Pacific Market Analysis
6. Asia Pacific Lithotripsy Market Analysis - by Type
7. Asia Pacific Lithotripsy Market Analysis - by Intracorporeal Lithotripsy Devices by Indications
8. Asia Pacific Lithotripsy Market Analysis - by PCNL Devices Type
9. Asia Pacific Lithotripsy Market Analysis - by PCNL Devices by Laser Component
10. Asia Pacific Lithotripsy Market Analysis - by PCNL Devices by Ultrasonic and Combination Component
11. Asia Pacific Lithotripsy Market Analysis - by Ureteroscopy Technique
12. Asia Pacific Lithotripsy Market Analysis - by Ureteroscopy Laser by Component
13. Asia Pacific Lithotripsy Market Analysis - by Ureteroscopy Laser by Type
14. Asia Pacific Lithotripsy Market Analysis - by Ureteroscopy Pneumatic Ballistic by Component
15. Asia Pacific Lithotripsy Market Analysis - by Application
16. Asia Pacific Lithotripsy Market Analysis - by Bladder Stones Technique Type
17. Asia Pacific Lithotripsy Market Analysis - by End-user
18. Asia Pacific Lithotripsy Market - Country Analysis
19. Competitive Landscape
20. Company Profiles
21. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Asia Pacific Lithotripsy Market include:- Becton Dickinson and Co
- Boston Scientific Corp
- Cook Medical Holdings LLC
- DirexGroup
- Dornier MedTech
- Edap Tms SA
- ELMED Medical Systems
- EMS Electro Medical Systems SA (EMS+)
- Karl Storz SE & Co KG
- NOVAmedtk
- Olympus Corp
- Potent Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 165 |
| Published | April 2025 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value in 2023 | 235.12 Million in 2023 |
| Forecasted Market Value by 2031 | 419.89 Million by 2031 |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 13 |
